Compounds > deoxyglucose
Page last updated: 2024-09-02

deoxyglucose and Lymphoma, B-Cell

deoxyglucose has been researched along with Lymphoma, B-Cell in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knudson, CM; Kuwana, T; Martin, SM; Rutkowski, DT; Spitz, DR; Zagorodna, O1
Bénéteau, M; Carles, M; Chiche, J; Cornille, A; Jacquin, MA; Marchetti, S; Meynet, O; Pradelli, LA; Ricci, JE; Zunino, B1
Altboum, I; Fingrut, O; Flescher, E; Goldin, N; Reischer, D; Rotem, R; Zan-Bar, I1
Beaney, RP; Chevretton, EB; Walsh, RM; Wong, WL1

Other Studies

4 other study(ies) available for deoxyglucose and Lymphoma, B-Cell

ArticleYear
2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines.
    Oncogene, 2012, May-31, Volume: 31, Issue:22

    Topics: Animals; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Bcl-2-Like Protein 11; Biphenyl Compounds; Blotting, Western; Caspases; Cell Proliferation; Cells, Cultured; Deoxyglucose; Flow Cytometry; Immunoprecipitation; Lymphoma, B-Cell; Lymphoma, T-Cell; Membrane Proteins; Mice; Mice, Inbred C57BL; Nitrophenols; Piperazines; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Thymocytes

2012
Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Dec-04, Volume: 109, Issue:49

    Topics: Animals; Antimetabolites, Antineoplastic; Blotting, Western; Calreticulin; Cell Death; Cell Line, Tumor; Deoxyglucose; Drug Therapy, Combination; Etoposide; Glycolysis; Kaplan-Meier Estimate; Lymphocyte Activation; Lymphoma, B-Cell; Mice; Mice, Inbred C57BL; Mice, Transgenic; RNA Interference; T-Lymphocytes

2012
Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells.
    British journal of pharmacology, 2005, Volume: 146, Issue:6

    Topics: Acetates; Adenosine Triphosphate; Antibiotics, Antineoplastic; Bleomycin; Cell Survival; Clone Cells; Cyclopentanes; Deoxyglucose; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Immunoblotting; Lymphoma, B-Cell; Mutation; Oligomycins; Oxylipins; Plant Growth Regulators; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Zinostatin

2005
The use of PET-18FDG imaging in the clinical evaluation of head and neck lymphoma.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1996, Volume: 8, Issue:1

    Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hyperplasia; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed

1996